Gene475
ATOX1: antioxidant 1 copper chaperone
Cite this record
ConductScience Library. ATOX1: antioxidant 1 copper chaperone. Genes, record 475. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/475
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O00244 | Copper transport protein ATOX1 | 68 | 17 | Ensembl, GeneID, HGNC |
Source UniProt
Patents124
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260196299 A1 | 2026-07-09 | 295 | O00244 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 38523 | O00244 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 38524 | O00244 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 38525 | O00244 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 5078 | O00244 | Espacenet |
| US 20250320254 A1 | 2025-10-16 | 5078 | O00244 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 5078 | O00244 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 5546 | O00244 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 5548 | O00244 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 5551 | O00244 | Espacenet |
NIH grants503
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ATOX1 papers | Newest fiscal year |
|---|---|---|---|
| R01DK071865 | Molecular Mechanisms of Active Copper Transport | 13 | 2025 |
| I01BX001232 | Cu importer CTR1 Cys189 oxidation in atherosclerosis | 8 | 2025 |
| R01GM079465 | Chemical Probes to Study Copper Biology | 4 | 2025 |
| T32CA121938 | UCSD Cancer Center Training Program in Drug Development | 4 | 2025 |
| P30ES019776 | HERCULES: Exposome Research Center | 3 | 2025 |
| P20GM103395 | Alaska INBRE 5 One Health | 2 | 2025 |
| P20GM113226 | Hepatobiology and Toxicology COBRE | 2 | 2025 |
| P30CA015083 | Mayo Clinic Comprehensive Cancer Center Support Grant | 2 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 2 | 2025 |
| P30ES010126 | UNC Center for Environmental Health and Susceptibility | 2 | 2025 |
Source NIH's project files
Papers1,032
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative gene ontology-driven analysis of the eutopic endometrium reveals key dysregulated functionomes and pathways in endometriosis. | J Chin Med Assoc | 2026 | 42037118 | PubTator, text mining | PubMed |
| Construction of ATOX1 targeted nano gel based on cuproptosis mechanism and its role in reversing TACE refractoriness of hepatocellular carcinoma. | J Nanobiotechnology | 2026 | 42035173 | PubTator, text mining | PubMed |
| Atox1 promotes CRC progression by protecting DNA damage through interacts with a novel copper-binding protein PARP1. | Cell Commun Signal | 2026 | 41913235 | PubTator, text mining | PubMed |
| Multifaceted Role of Copper Homeostasis in Gut Health: From Molecular Mechanisms to Therapeutic Interventions. | Cells | 2026 | 41892335 | PubTator, text mining | PubMed |
| Cuproptosis in spinal cord injury: emerging mechanisms and immunological relevance. | Ann Med | 2026 | 41883033 | PubTator, text mining | PubMed |
| Thioxanthone-Mediated Cytoprotection Against Cisplatin Toxicity: Exploring the Potential Involvement of P-Glycoprotein Through Computational and Experimental Approaches. | J Xenobiot | 2026 | 41874126 | PubTator, text mining | PubMed |
| The role of copper and cuproptosis in digestive system cancers: novel therapeutic strategies and mechanistic insights. | Cancer Biol Ther | 2026 | 41837409 | PubTator, text mining | PubMed |
| Targeting regulated cell death pathways in lung cancer: mechanisms, therapeutic strategies, and clinical translation. | Front Immunol | 2026 | 41789093 | PubTator, text mining | PubMed |
| Precision Diagnosis of Wilson Disease Using a MultiGene Panel: Insights From a Prospective Cohort Study. | Neurol Genet | 2026 | 41788301 | PubTator, text mining | PubMed |
| Copper Homeostasis and Cuproptosis in Neurological Disorders. | Drug Des Devel Ther | 2026 | 41783572 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/475
GET https://conductscience.org/api/genes/v1/475/patents?page=2